Terms: = Head and neck cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Treatment
42 results:
1. Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma.
Dal Lago EA; Sousa LG; Yang Z; Hoff CO; Bonini F; Sawyer M; Wang K; Lewis W; Wahid KA; Hanna EY; El-Naggar A; Fuller CD; Kundu S; Godoy M; Ferrarotto R
Oral Oncol; 2024 Apr; 151():106759. PubMed ID: 38507991
[TBL] [Abstract] [Full Text] [Related]
2. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
[TBL] [Abstract] [Full Text] [Related]
3. Contrast-enhanced CT radiomics features to preoperatively identify differences between tumor and proximal tumor-adjacent and tumor-distant tissues of resectable esophageal squamous cell carcinoma.
Gao D; Tan BG; Chen XQ; Zhou C; Ou J; Guo WW; Zhou HY; Li R; Zhang XM; Chen TW
Cancer Imaging; 2024 Jan; 24(1):11. PubMed ID: 38243339
[TBL] [Abstract] [Full Text] [Related]
4. Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.
Watanabe K; Igarashi T; Uchiyama M; Ishigaki T; Ojiri H
Jpn J Radiol; 2024 Apr; 42(4):391-397. PubMed ID: 38212512
[TBL] [Abstract] [Full Text] [Related]
5. Radiomic analysis of MRI for prediction of response to induction chemotherapy in nasopharyngeal carcinoma patients.
Wang A; Xu H; Zhang C; Ren J; Liu J; Zhou P
Clin Radiol; 2023 Sep; 78(9):e644-e653. PubMed ID: 37331848
[TBL] [Abstract] [Full Text] [Related]
6. Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.
Medas F; Dobrinja C; Al-Suhaimi EA; Altmeier J; Anajar S; Arikan AE; Azaryan I; Bains L; Basili G; Bolukbasi H; Bononi M; Borumandi F; Bozan MB; Brenta G; Brunaud L; Brunner M; Buemi A; Canu GL; Cappellacci F; Cartwright SB; Castells Fusté I; Cavalheiro B; Cavallaro G; Chala A; Chan SYB; Chaplin J; Cheema MS; Chiapponi C; Chiofalo MG; Chrysos E; D'Amore A; de Cillia M; De Crea C; de Manzini N; de Matos LL; De Pasquale L; Del Rio P; Demarchi MS; Dhiwakar M; Donatini G; Dora JM; D'Orazi V; Doulatram Gamgaram VK; Eismontas V; Kabiri EH; El Malki HO; Elzahaby I; Enciu O; Eskander A; Feroci F; Figueroa-Bohorquez D; Filis D; François G; Frías-Fernández P; Gamboa-Dominguez A; Genc V; Giordano D; Gómez-Pedraza A; Graceffa G; Griffin J; Guerreiro SC; Gupta K; Gupta KK; Gurrado A; Hajiioannou J; Hakala T; Harahap WA; Hargitai L; Hartl D; Hellmann A; Hlozek J; Hoang VT; Iacobone M; Innaro N; Ioannidis O; Jang JHI; Xavier-Junior JC; Jovanovic M; Kaderli RM; Kakamad F; Kaliszewski K; Karamanliev M; Katoh H; Košec A; Kovacevic B; Kowalski LP; Králik R; Yadav SK; Kumorová A; Lampridis S; Lasithiotakis K; Leclere JC; Leong EKF; Leow MK; Lim JY; Lino-Silva LS; Liu SYW; Llorach NP; Lombardi CP; López-Gómez J; Lori E; Quintanilla-Dieck L; Lucchini R; Madani A; Manatakis D; Markovic I; Materazzi G; Mazeh H; Mercante G; Meyer-Rochow GY; Mihaljevic O; Miller JA; Minuto M; Monacelli M; Mulita F; Mullineris B; Muñoz-de-Nova JL; Muradás Girardi F; Nader S; Napadon T; Nastos C; Offi C; Ronen O; Oragano L; Orois A; Pan Y; Panagiotidis E; Panchangam RB; Papavramidis T; Parida PK; Paspala A; Pérez ÒV; Petrovic S; Raffaelli M; Ramacciotti CF; Ratia Gimenez T; Rivo Vázquez Á; Roh JL; Rossi L; Sanabria A; Santeerapharp A; Semenov A; Seneviratne S; Serdar A; Sheahan P; Sheppard SC; Slotcavage RL; Smaxwil C; Kim SY; Sorrenti S; Spartalis E; Sriphrapradang C; Testini M; Turk Y; Tzikos G; Vabalayte K; Vargas-Osorio K; Vázquez Rentería RS; Velázquez-Fernández D; Vithana SMP; Yücel L; Yulian ED; Zahradnikova P; Zarogoulidis P; Ziablitskaia E; Zolotoukho A; Calò PG;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):402-413. PubMed ID: 37127041
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition Mechanism of PinX1 Gene on cancer Stem Cells of Nasopharyngeal Carcinoma.
Xiang H; Liu L; Yuan Y; Liu L; Chen Z
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):182-186. PubMed ID: 37114251
[TBL] [Abstract] [Full Text] [Related]
8. Preoperative Prediction of Sinonasal Inverted Papilloma-associated Squamous Cell Carcinoma (IP-SCC).
Park MJ; Cho W; Kim JH; Chung YS; Jang YJ; Yu MS
Laryngoscope; 2023 Oct; 133(10):2502-2510. PubMed ID: 36683553
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic Accuracy of
Murtojärvi S; Malaspina S; Kinnunen I; Tuokkola T; Honka MJ; Saunavaara V; Tolvanen T; Schrey A; Kemppainen J
Contrast Media Mol Imaging; 2022; 2022():8676787. PubMed ID: 36082064
[TBL] [Abstract] [Full Text] [Related]
10. [Preventing and treating anterior commissure adhesion with mucosal flap: a study in canines and clinical cases].
Li JY; Li XM; Cui XD; Hu XQ; Yu PC; Sun GB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Feb; 57(2):161-167. PubMed ID: 35196759
[No Abstract] [Full Text] [Related]
11. Veliparib in Combination With Platinum-Based Chemotherapy for First-Line treatment of Advanced Squamous Cell Lung cancer: A Randomized, Multicenter Phase III Study.
Ramalingam SS; Novello S; Guclu SZ; Bentsion D; Zvirbule Z; Szilasi M; Bernabe R; Syrigos K; Byers LA; Clingan P; Bar J; Vokes EE; Govindan R; Dunbar M; Ansell P; He L; Huang X; Sehgal V; Glasgow J; Bach BA; Mazieres J
J Clin Oncol; 2021 Nov; 39(32):3633-3644. PubMed ID: 34436928
[TBL] [Abstract] [Full Text] [Related]
12. Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma.
Nakaya S; Ogawa R; Hayakawa S; Fujihata S; Okubo T; Sagawa H; Tanaka T; Takahashi H; Matsuo Y; Takiguchi S
World J Surg Oncol; 2021 Jul; 19(1):217. PubMed ID: 34281546
[TBL] [Abstract] [Full Text] [Related]
13. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
Shah K; Panchal S; Patel B
Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
[TBL] [Abstract] [Full Text] [Related]
14. Volume-based algorithm of lung dose optimization in novel dynamic arc radiotherapy for esophageal cancer.
Lin KH; Hsu CX; Wang SY; Mok GSP; Chang CH; Tien HJ; Shueng PW; Wu TH
Sci Rep; 2021 Feb; 11(1):4360. PubMed ID: 33623071
[TBL] [Abstract] [Full Text] [Related]
15. Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.
Patil V; Noronha V; Dhumal SB; Joshi A; Menon N; Bhattacharjee A; Kulkarni S; Ankathi SK; Mahajan A; Sable N; Nawale K; Bhelekar A; Mukadam S; Chandrasekharan A; Das S; Vallathol D; D'Souza H; Kumar A; Agrawal A; Khaddar S; Rathnasamy N; Shenoy R; Kashyap L; Rai RK; Abraham G; Saha S; Majumdar S; Karuvandan N; Simha V; Babu V; Elamarthi P; Rajpurohit A; Kumar KAP; Srikanth A; Ravind R; Banavali S; Prabhash K
Lancet Glob Health; 2020 Sep; 8(9):e1213-e1222. PubMed ID: 32827483
[TBL] [Abstract] [Full Text] [Related]
16. Increased Expression of PD-1 and PD-L1 in Patients With Laryngotracheal Stenosis.
Davis RJ; Lina I; Ding D; Engle EL; Taube J; Gelbard A; Hillel AT
Laryngoscope; 2021 May; 131(5):967-974. PubMed ID: 32557663
[TBL] [Abstract] [Full Text] [Related]
17.
DE Sanctis V; Belgioia L; Cante D; LA Porta MR; Caspiani O; Guarnaccia R; Argenone A; Muto P; Musio D; DE Felice F; Maurizi F; Bunkhelia F; Ruo Redda MG; Reali A; Valeriani M; Osti MF; Alterio D; Bacigalupo A; Russi EG
Anticancer Res; 2019 Apr; 39(4):1935-1942. PubMed ID: 30952736
[TBL] [Abstract] [Full Text] [Related]
18. Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma.
Beyaert S; Hamoir M; Van Maanen A; Grégoire V; Schmitz S
Eur J Surg Oncol; 2019 Jul; 45(7):1188-1195. PubMed ID: 30940421
[TBL] [Abstract] [Full Text] [Related]
19. Oncologic and functional outcomes of salvage supracricoid partial laryngectomy.
Kim JH; Kim WS; Koh YW; Kim SH; Byeon HK; Choi EC
Acta Otolaryngol; 2018 Dec; 138(12):1117-1122. PubMed ID: 30702020
[TBL] [Abstract] [Full Text] [Related]
20. Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.
Jing Y; Yang Y; Hao F; Song Y; Zhang X; Zhang Y; Huang X; Hu Q; Ni Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341240
[No Abstract] [Full Text] [Related]
[Next]
